oral leukoplakia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients clinically and histopathologically diagnosed with oral leukoplakia 2. Aged 18 years or older 3. Willing to participate in the study and sign an informed consent form 4. Patients who, based on routine initial examinations (such as complete blood count, liver and kidney function tests, fasting blood glucose, blood lipids, and coagulation function), are determined to be in a general condition suitable for the proposed treatment plan
Exclusion criteria
Exclusion criteria: 1.Patients with unassessable therapeutic efficacy resulting from untimely follow-up 2. Patients with missing baseline information 3. Pregnant or lactating women 4.Patients with porphyria, porphyrin allergy, photosensitivity, allergy to topical aminolevulinic acid hydrochloride powder, allergy to local anesthetics, or coagulation disorders 5. Patients with other severe systemic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malignant transformation event;Recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lesion area before treatment;Lesion area after treatment;Number of treatment sessions; | — |
Countries
China
Contacts
West China Hospital of Stomatology, Sichuan University